Walleye Capital LLC Puma Biotechnology, Inc. Transaction History
Walleye Capital LLC
- $20.4 Billion
- Q1 2025
A detailed history of Walleye Capital LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 13,055 shares of PBYI stock, worth $47,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,055
Previous 38,845
66.39%
Holding current value
$47,520
Previous $118,000
67.8%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PBYI
# of Institutions
116Shares Held
30.9MCall Options Held
32.7KPut Options Held
200-
Acorn Capital Advisors, LLC New York, NY3.94MShares$14.3 Million8.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$13.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$13 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$7.18 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.83MShares$6.66 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $166M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...